A parliamentary committee has recommended delaying the planned expansion of Medical Assistance in Dying (MAiD) eligibility for individuals whose sole underlying condition is mental illness, reigniting debate over one of Canada’s most sensitive healthcare and ethical issues.

The recommendation comes amid ongoing concerns from medical professionals, mental health advocates, and policymakers who argue that Canada’s healthcare system may not yet be adequately prepared to assess complex mental illness cases under the MAiD framework. Committee members cited the need for stronger safeguards, improved clinical guidelines, and greater access to mental health services before any expansion moves forward.

Supporters of the pause argue that mental illnesses can be difficult to predict and treat, making it challenging to determine when a condition is truly irremediable. They believe additional time is needed to ensure vulnerable individuals are protected and that decisions regarding assisted dying are made with the highest level of care and oversight.

Others, however, have criticized the recommendation, arguing that delaying eligibility limits personal autonomy and access to a legal healthcare option for individuals experiencing prolonged and severe psychological suffering. Advocates say competent adults should have the right to make end-of-life decisions regardless of whether their condition is physical or mental.

The debate highlights broader concerns about the availability of mental health services across Canada. Critics of expansion have pointed to lengthy wait times, uneven access to treatment, and gaps in psychiatric care, arguing that patients should have access to comprehensive support before considering MAiD.

The federal government has previously delayed the implementation of MAiD eligibility for mental illness, citing similar concerns from healthcare providers and provincial authorities. The latest recommendation suggests that lawmakers remain divided over whether the healthcare system is ready for such a significant policy change.

As discussions continue, the future of MAiD expansion for mental illness remains uncertain. The committee’s recommendation is expected to influence upcoming legislative debates, while healthcare professionals, patient advocates, and policymakers continue to weigh issues of patient rights, safety, and ethical responsibility.